Standard Chemical & Pharmaceutical Co Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: 0.057x

Standard Chemical & Pharmaceutical Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Standard Chemical & Pharmaceutical Co Ltd (1720) has a cash flow conversion efficiency ratio of 0.057x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$510.55 Million ≈ $16.09 Million USD) by net assets (NT$9.02 Billion ≈ $284.22 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Standard Chemical & Pharmaceutical Co Ltd (2002–2024)

Cash flow conversion efficiency of Standard Chemical & Pharmaceutical Co Ltd from 2002 to 2024. This chart illustrates how Standard Chemical & Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Standard Chemical & Pharmaceutical Co Lt (1720) share price today for real-time trading data and today's change.

Standard Chemical & Pharmaceutical Co Ltd Cash Flow Conversion Ratio Explained

Standard Chemical & Pharmaceutical Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Standard Chemical & Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Standard Chemical & Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Also see Standard Chemical & Pharmaceutical Co Lt market capitalisation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
D. Boral Acquisition I Corp. Class A Ordinary Shares NASDAQ:DBCA	-0.001x
HLE Glascoat Limited NSE:HLEGLAS	0.121x
E1 Corporation KO:017940	-0.056x
Stillfront Group AB (publ) ST:SF	0.040x
Ranpak Holdings Corp NYSE:PACK	0.005x
Jiangsu Lidao New Material Co Ltd Class A SHG:603937	0.018x
Wuhan Nusun Landscape Co Ltd SHE:300536	0.000x
Skymoons Technology Inc. KQ:033790	0.060x

Annual Cash Flow Conversion Efficiency for Standard Chemical & Pharmaceutical Co Ltd (2002–2024)

The table below shows the annual cash flow conversion efficiency of Standard Chemical & Pharmaceutical Co Ltd from 2002 to 2024. Review Standard Chemical & Pharmaceutical Co Lt (1720) free cash flow to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	NT$8.98 Billion ≈ $282.80 Million	NT$1.69 Billion ≈ $53.40 Million	0.189x	+14.97%
2023-12-31	NT$8.14 Billion ≈ $256.37 Million	NT$1.34 Billion ≈ $42.11 Million	0.164x	-0.53%
2022-12-31	NT$7.44 Billion ≈ $234.26 Million	NT$1.23 Billion ≈ $38.68 Million	0.165x	+35.76%
2021-12-31	NT$6.80 Billion ≈ $214.23 Million	NT$827.03 Million ≈ $26.06 Million	0.122x	-35.32%
2020-12-31	NT$4.91 Billion ≈ $154.56 Million	NT$922.58 Million ≈ $29.07 Million	0.188x	+36.97%
2019-12-31	NT$4.65 Billion ≈ $146.39 Million	NT$637.94 Million ≈ $20.10 Million	0.137x	+20.22%
2018-12-31	NT$4.25 Billion ≈ $133.78 Million	NT$484.94 Million ≈ $15.28 Million	0.114x	-32.29%
2017-12-31	NT$4.20 Billion ≈ $132.39 Million	NT$708.74 Million ≈ $22.33 Million	0.169x	+131.78%
2016-12-31	NT$4.20 Billion ≈ $132.22 Million	NT$305.38 Million ≈ $9.62 Million	0.073x	-56.54%
2015-12-31	NT$3.89 Billion ≈ $122.46 Million	NT$650.87 Million ≈ $20.51 Million	0.167x	+3.69%
2014-12-31	NT$3.61 Billion ≈ $113.60 Million	NT$582.30 Million ≈ $18.35 Million	0.161x	+35.41%
2013-12-31	NT$3.58 Billion ≈ $112.87 Million	NT$427.26 Million ≈ $13.46 Million	0.119x	-1.97%
2012-12-31	NT$3.31 Billion ≈ $104.17 Million	NT$402.25 Million ≈ $12.67 Million	0.122x	-6.33%
2011-12-31	NT$3.12 Billion ≈ $98.36 Million	NT$405.49 Million ≈ $12.78 Million	0.130x	+38.92%
2010-12-31	NT$2.91 Billion ≈ $91.81 Million	NT$272.47 Million ≈ $8.58 Million	0.094x	-58.59%
2009-12-31	NT$2.81 Billion ≈ $88.50 Million	NT$634.23 Million ≈ $19.98 Million	0.226x	-18.22%
2008-12-31	NT$2.60 Billion ≈ $82.07 Million	NT$719.17 Million ≈ $22.66 Million	0.276x	+119.99%
2007-12-31	NT$2.58 Billion ≈ $81.23 Million	NT$323.60 Million ≈ $10.20 Million	0.126x	-9.88%
2006-12-31	NT$2.58 Billion ≈ $81.17 Million	NT$358.75 Million ≈ $11.30 Million	0.139x	-9.29%
2005-12-31	NT$2.42 Billion ≈ $76.09 Million	NT$370.77 Million ≈ $11.68 Million	0.154x	-17.69%
2004-12-31	NT$1.80 Billion ≈ $56.67 Million	NT$335.45 Million ≈ $10.57 Million	0.187x	+13.25%
2003-12-31	NT$1.66 Billion ≈ $52.21 Million	NT$272.89 Million ≈ $8.60 Million	0.165x	+75.71%
2002-12-31	NT$1.58 Billion ≈ $49.67 Million	NT$147.75 Million ≈ $4.66 Million	0.094x	--

About Standard Chemical & Pharmaceutical Co Ltd

TW:1720 Taiwan Drug Manufacturers - Specialty & Generic

Market Cap

$311.33 Million

NT$9.88 Billion TWD

Market Cap Rank

#14319 Global

#573 in Taiwan

Share Price

NT$55.30

Change (1 day)

-1.95%

52-Week Range

NT$55.30 - NT$65.60

All Time High

NT$77.40